Concepedia

LBA47 Osimertinib as adjuvant therapy in patients (pts) with resected EGFR-mutated (EGFRm) stage IB-IIIA non-small cell lung cancer (NSCLC): Updated results from ADAURA

Masahiro Tsuboi, Yi‐Long Wu, C Grohé, Thomas John, M. Majem Tarruella, J. Wang, T. Kato, J.W. Goldman, S-W. Kim, Chong‐Jen Yu,

Annals of Oncology · 2022 · 23 citations · 0 references

DOI

Concepts